BioLife Solutions, Inc. (NASDAQ:BLFS) enjoyed a 264.74% run-up in share price since hitting record low of $4.85. The stock managed 4.74% rise and now stands at $17.69 as of 3/14/2019. At a recent session, the prices were hovering between $16.61 and $18.21. This company shares are 13.06% off its target price of $20 and the current market capitalization stands at $333.63M. The recent change has given its price a 17.26% lead over SMA 50 and -32.87% deficit over its 52-week high. The stock witnessed 7.73% gains, 53.29% gains and -9.65% declines for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found BLFS’s volatility during a week at 5.76% and during a month it has been found around 6.24%.BioLife Solutions, Inc. (BLFS) Top Holders
Institutional investors currently hold around $127 million or 42.5% in BLFS stock. Look at its top three institutional owners: Casdin Capital, Llc owns $41.02 million in BioLife Solutions, Inc., which represents roughly 12.29% of the company’s market cap and approximately 32.3% of the institutional ownership. Similar statistics are true for the second largest owner, Sandler Capital Management, which owns 968,073 shares of the stock are valued at $16.35 million. The third largest holder is Vanguard Group Inc, which currently holds $9.41 million worth of this stock and that ownership represents nearly 2.82% of its market capitalization.BioLife Solutions, Inc. 13F Filings
At the end of December reporting period, 31 institutional holders increased their position in BioLife Solutions, Inc. (NASDAQ:BLFS) by some 1,220,089 shares, 28 decreased positions by 1,291,820 and 9 held positions by 5,012,200. That puts total institutional holdings at 7,524,109 shares, according to SEC filings. The stock grabbed 14 new institutional investments totaling 671,125 shares while 15 institutional investors sold out their entire positions totaling 759,060 shares.BioLife Solutions, Inc. (BLFS) Analyst Guide
Several analysts have released their opinion on BioLife Solutions, Inc. (NASDAQ:BLFS), with 2 analysts believing it is a strong buy. Whereas 0 of them predict the stock is a hold. Also, there are 2 buy, 0 sell and 0 strong sell ratings, collectively assigning a 1.5 average brokerage recommendation [T1].